Candel Therapeutics, Inc.
Candel Therapeutics, Inc. (CADL) — Form 424B5: Prospectus
About this filing
Candel Therapeutics, Inc. (CADL) filed Form 424B5 (prospectus) with the SEC on Nov 12, 2026.
Key facts
- Document
- 424B5
More CADL filings
- SC 13G/A
Filed Nov 16, 2026
- 8-K
Filed Nov 12, 2026
- 10-Q
Filed Nov 12, 2026
- 8-K
Filed Nov 12, 2026
- 4
Filed Nov 5, 2026
- 3
Filed Nov 5, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.